Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Diagnostics Announces New Marketing Manager and Provides Corporate Update on Sales

TheNewsWire October 17, 2018

Ventripoint Closes First Tranche of Non-Brokered Private Placement

TheNewsWire September 5, 2018

Ventripoint Announces $1,000,000 Non-Brokered Private Placement

TheNewsWire August 15, 2018

Ventripoint Provides Corporate Update on Development of Artificial Intelligence Engine to Automate Heart Analysis

TheNewsWire August 13, 2018

Ventripoint Provides Corporate Update on Development of Next-Generation Products

TheNewsWire August 8, 2018

Ventripoint Provides Corporate Update on Sales and Marketing

TheNewsWire August 1, 2018

Mazankowski Alberta Heart Institute Starts Study Comparing Ventripoint Heart Analysis to Contrast Enhanced 2D Echocardiography

TheNewsWire July 17, 2018

MD Anderson Cancer Center is the First Hospital in USA to Order the VMS+ Complete Heart Analysis System

TheNewsWire June 5, 2018

IIROC Trading Resumption - VPT

Canada NewsWire May 16, 2018

Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System Using 2D Ultrasound

GlobeNewswire May 16, 2018

IIROC Trading Halt - VPT

Canada NewsWire May 15, 2018

Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System using 2D Ultrasound

TheNewsWire May 15, 2018

Ventripoint Attends the Canadian Society of Echocardiography Conference in Toronto

TheNewsWire April 23, 2018

Ventripoint to Issue Shares for Service to CEO and Consultants

TheNewsWire March 29, 2018

Ventripoint and Ryerson University Have Been Approved for Government Funding to Advance Artificial Intelligence in Medical Imaging

TheNewsWire March 26, 2018

Ventripoint Appoints Dr. Samuel Schwartz Chair of Business Advisory Committee

TheNewsWire March 14, 2018

Ventripoint Named to 2018 TSX Venture 50 Group of Top Performing Companies

TheNewsWire February 22, 2018

First Ventripoint Whole Heart System Operational at University of Alberta Mazankowski Heart Institute

TheNewsWire February 21, 2018

Ventripoint Adds Hospital Networking Expert to Implementation Team

TheNewsWire February 7, 2018

IIROC Trading Resumption - VPT

Canada NewsWire January 17, 2018